Oncotarget

Research Perspectives:

Cdk5 and Foxc2 – a new relationship in the lymphatic vasculature

Johanna Liebl _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:21799-21801. https://doi.org/10.18632/oncotarget.4848

Metrics: PDF 701 views  |   HTML 883 views  |   ?  


Abstract

Johanna Liebl1

1 Ludwig Maximilians-University Munich, Department of Pharmacy, Pharmaceutical Biology, Munich, Germany

Correspondence to:

Johanna Liebl, email:

Keywords: chromosome section, Cdk5, Foxc2, lymphatic vessels, lymphatic valves

Received: June 19, 2015 Accepted: June 23, 2015 Published: July 13, 2015

Abstract

Lymphatic vessel dysfunction is associated with various pathologic conditions, including immunologic disorders, lymphedema, as well as tumor dissemination. Yet, the knowledge about the regulation of lymphatic vessel development is still limited. Our study elucidates cyclin dependent kinase 5 (Cdk5) as an essential player in the development of lymphatic vessels. Deletion of Cdk5 in the mouse endothelium results in severe lymphedema formation and embryonic lethality. On the mechanistic level, we show that Cdk5 phosphorylates the forkhead transcription factor Foxc2 which regulates Foxc2-dependent transcription. In summary, our study elucidates the Cdk5-Foxc2 interaction as a critical regulator of lymphatic vessel development.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 4848